» Articles » PMID: 28978073

Presence of Embryonic DNA in Culture Medium

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Oct 6
PMID 28978073
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Preimplantation genetic diagnosis (PGD) has successfully assisted couples with genetic diseases to conceive healthy babies during the past decades. However, biopsy of the blastomere has potential lesion to the embryos which commonly results in abortion. Thus, a noninvasive PGD is needed. In the past, the presence of genetic materials in maternal plasma or serum has triggered a great innovation of noninvasive prenatal diagnosis. Nevertheless, it is not clear whether embryonic DNA is also present in embryonic culture medium. Here, a rapid-boiling method has been used to harvest DNA from the medium or the discarded embryos, following Polymerase Chain Reaction (PCR) was applied to detect the dissociative DNA by amplifying SRY gene (Y-chromosome). For the first time, the Y sequences were detected in the medium which were used to culture embryo for above 3 days. None of the positive signal was examined in Day 1 and Day 2 embryonic culture medium. Our findings suggest that the Y chromosome fragments from the embryo may release into its culture medium. If validated in a larger cohort, detection of SRY gene may prove to be a useful method to screen Y-linked genetic disease. More importantly, detecting the free DNA in the embryonic culture medium may represent a novel strategy for noninvasive PGD.

Citing Articles

Advancements and Challenges in Preimplantation Genetic Testing for Aneuploidies: In the Pathway to Non-Invasive Techniques.

Del Arco de la Paz A, Gimenez-Rodriguez C, Selntigia A, Meseguer M, Galliano D Genes (Basel). 2025; 15(12.

PMID: 39766880 PMC: 11675356. DOI: 10.3390/genes15121613.


Non Invasive Preimplantation Testing for Aneuploidies in Assisted Reproduction: A SWOT Analysis.

de Albornoz E, Dominguez Arroyo J, Iriarte Y, Vendrell X, Vidal V, Roig M Reprod Sci. 2024; 32(1):1-14.

PMID: 39433699 DOI: 10.1007/s43032-024-01698-2.


An Update on Non-invasive Approaches for Genetic Testing of the Preimplantation Embryo.

Kakourou G, Mamas T, Vrettou C, Traeger-Synodinos J Curr Genomics. 2023; 23(5):337-352.

PMID: 36778192 PMC: 9878856. DOI: 10.2174/1389202923666220927111158.


A prospective study to evaluate the gender prediction of blastocysts by using cell-free DNA within a culture medium.

Barzanouni S, Moramezi F, Zargar M, Galehdari H, Hemadi M Int J Reprod Biomed. 2022; 20(7):561-568.

PMID: 36187736 PMC: 9446442. DOI: 10.18502/ijrm.v20i7.11558.


Isolation of cfDNA from spent culture media and its association with implantation rate and maternal immunomodulation.

Alizadegan A, Akbarzadeh M, Soltani-Zangbar M, Sambrani R, Hamdi K, Ghasemzadeh A BMC Res Notes. 2022; 15(1):259.

PMID: 35842732 PMC: 9288726. DOI: 10.1186/s13104-022-06151-8.


References
1.
Sermon K, Van Steirteghem A, Liebaers I . Preimplantation genetic diagnosis. Lancet. 2004; 363(9421):1633-41. DOI: 10.1016/S0140-6736(04)16209-0. View

2.
Schoolcraft W, Fragouli E, Stevens J, Munne S, Katz-Jaffe M, Wells D . Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril. 2009; 94(5):1700-6. DOI: 10.1016/j.fertnstert.2009.10.015. View

3.
Palini S, Galluzzi L, De Stefani S, Bianchi M, Wells D, Magnani M . Genomic DNA in human blastocoele fluid. Reprod Biomed Online. 2013; 26(6):603-10. DOI: 10.1016/j.rbmo.2013.02.012. View

4.
Stigliani S, Persico L, Lagazio C, Anserini P, Venturini P, Scaruffi P . Mitochondrial DNA in Day 3 embryo culture medium is a novel, non-invasive biomarker of blastocyst potential and implantation outcome. Mol Hum Reprod. 2014; 20(12):1238-46. DOI: 10.1093/molehr/gau086. View

5.
de Vos A, Staessen C, De Rycke M, Verpoest W, Haentjens P, Devroey P . Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. Hum Reprod. 2009; 24(12):2988-96. DOI: 10.1093/humrep/dep251. View